← Back to headlines
Sun Pharma Expands with $12 Billion US Deal
India's Sun Pharma is set to enter the "big leagues" of the pharmaceutical industry following a significant $12 billion deal in the United States. This acquisition or partnership is expected to substantially expand its market presence and influence.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
